- Home
- OXM vs LXRX Comparison
OXM vs LXRX Comparison
Compare OXM & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OXM | LXRX |
|---|---|---|
| Founded | 1942 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 579.9M | 547.4M |
| IPO Year | 1994 | 2000 |
Fundamental Metrics
Financial Performance| Metric | OXM | LXRX |
|---|---|---|
| Price | $38.28 | $1.69 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $44.80 | $4.63 |
| AVG Volume (30 Days) | 209.9K | ★ 2.2M |
| Earning Date | 03-10-2026 | 06-08-2026 |
| Dividend Yield | ★ 7.36% | N/A |
| EPS Growth | 53.66 | ★ 77.78 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,516,601,000.00 | $49,803,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.68 | $22.16 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $30.57 | $0.32 |
| 52 Week High | $64.39 | $1.83 |
Technical Indicators
Market Signals| Indicator | OXM | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 65.15 |
| Support Level | $36.10 | $1.08 |
| Resistance Level | $42.12 | $1.83 |
| Average True Range (ATR) | 1.71 | 0.12 |
| MACD | -0.30 | 0.02 |
| Stochastic Oscillator | 28.36 | 78.23 |
Price Performance
Historical ComparisonAbout OXM Oxford Industries Inc.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company generates majority of its revenue from the Tommy Bahama division.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.